The University of Texas at San Antonio is a public research university in San Antonio, Texas. With over 34,000 students across its four campuses spanning 758 acres, UTSA is the largest university in San Antonio and the eighth-largest by enrollment in the state of Texas.

During the past decade, University of Texas-San Antonio conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Texas-San Antonio" #1 sponsor was "The University of Texas at San Antonio" with 4 trials, followed by "Johns Hopkins University" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Texas-San Antonio" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Emissary International LLC" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "ALS Association" with 1 trials as a collaborator and "Agile Analytics, LLC" with 1 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "University of Texas-San Antonio" are "Attention Deficit Hyperactivity Disorder (ADHD)" (2 trials), "Breast Cancer" (2 trials), "Intracerebral Hemorrhage" (2 trials), "AIDS" (1 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "University of Texas-San Antonio" in a lesser frequency.

Most popular intervention types in "University of Texas-San Antonio" are "Drug" (15 trials), "Other" (7 trials), "Device" (4 trials), "Behavioral" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "SHP465" (2 trials), "Active Control" (1 trials), "Alteplase" (1 trials) and "Ambrisentan" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Texas-San Antonio" are 28 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Texas-San Antonio". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in University of Texas-San Antonio, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Texas-San Antonio, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".